Taiwan Looks To Generic Savings In HIV Drug Reimbursement To Build On Multinational Price Cuts
This article was originally published in PharmAsia News
Executive Summary
Following an agreement by six multinational firms – including GlaxoSmithKline and AbbVie – to cut prices for antiretrovirals, Taiwan’s Centers for Disease Control is looking to import generic drugs for its free HIV drug reimbursement program, which has met with success only to see costs explode.